Ikarian Capital
Latest statistics and disclosures from Ikarian Capital's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ALNY, CLDX, AXSM, XBI, KRTX, and represent 33.89% of Ikarian Capital's stock portfolio.
- Added to shares of these 10 stocks: AXSM (+$33M), ALNY (+$20M), KRTX (+$19M), ALT (+$14M), ESPR (+$13M), RLMD (+$11M), SRPT (+$9.4M), KZR (+$9.3M), LNTH (+$6.6M), ICPT (+$5.8M).
- Started 22 new stock positions in ALT, HRMY, ARDX, INSM, RGLS, CASI, CFRX, ESPR, KDNY, ITOS. COGT, TERN, EOLS, AXSM, PRAX, FULC, VRNA, BBIO, VRDN, KWEB, LNTH, SRPT.
- Reduced shares in these 10 stocks: XBI (-$44M), NBIX (-$38M), BCYC (-$37M), GILD (-$22M), RETA (-$17M), BMRN (-$16M), UTHR (-$14M), ZNTL (-$9.3M), SAGE (-$8.1M), Biohaven Pharmaceutical Holding (-$7.1M).
- Sold out of its positions in LIFE, ACAD, ACRS, AGEN, AKBA, AMYT, Applied Genetic Technol Corp C, APTO, ASND, ASMB.
- Ikarian Capital was a net seller of stock by $-123M.
- Ikarian Capital has $548M in assets under management (AUM), dropping by -27.67%.
- Central Index Key (CIK): 0001778253
Tip: Access up to 7 years of quarterly data
Positions held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv

Portfolio Holdings for Ikarian Capital
Ikarian Capital holds 115 positions in its portfolio as reported in the June 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Alnylam Pharmaceuticals Call Option (ALNY) | 10.4 | $57M | +54% | 392k | 145.85 | |
Celldex Therapeutics Com New Put Option (CLDX) | 8.2 | $45M | +12% | 1.7M | 26.96 | |
Axsome Therapeutics Put Option (AXSM) | 5.9 | $33M | NEW | 850k | 38.30 | |
Spdr Ser Tr S&p Biotech Put Option (XBI) | 4.7 | $26M | -62% | 350k | 74.27 | |
Karuna Therapeutics Ord Put Option (KRTX) | 4.6 | $25M | +300% | 200k | 126.52 | |
Amgen Call Option (AMGN) | 4.4 | $24M | -16% | 100k | 243.30 | |
Biogen Idec Call Option (BIIB) | 4.2 | $23M | 113k | 203.92 | ||
Horizon Therapeutics Pub L SHS (HZNP) | 3.8 | $21M | -3% | 260k | 79.76 | |
Kezar Life Sciences Call Option (KZR) | 3.7 | $21M | +82% | 2.5M | 8.27 | |
Altimmune Com New Call Option (ALT) | 2.6 | $14M | NEW | 1.2M | 11.70 | |
BioMarin Pharmaceutical Call Option (BMRN) | 2.5 | $14M | -54% | 167k | 82.88 | |
Esperion Therapeutics (ESPR) | 2.4 | $13M | NEW | 2.1M | 6.36 | |
Amylyx Pharmaceuticals Call Option (AMLX) | 2.1 | $12M | -7% | 597k | 19.26 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 2.1 | $11M | +60% | 40k | 281.77 | |
Gossamer Bio (GOSS) | 2.0 | $11M | +33% | 1.3M | 8.37 | |
Relmada Therapeutics Call Option (RLMD) | 2.0 | $11M | +2570% | 582k | 18.99 | |
Bellus Health Com New Call Option (BLU) | 1.9 | $10M | +22% | 1.1M | 9.24 | |
Milestone Pharmaceuticals Call Option (MIST) | 1.7 | $9.5M | -17% | 1.6M | 5.94 | |
United Therapeutics Corporation (UTHR) | 1.7 | $9.4M | -60% | 40k | 235.65 | |
Sarepta Therapeutics Call Option (SRPT) | 1.7 | $9.4M | NEW | 125k | 74.95 | |
Sage Therapeutics Call Option (SAGE) | 1.5 | $8.1M | -49% | 250k | 32.30 | |
Apellis Pharmaceuticals Call Option (APLS) | 1.4 | $7.5M | -5% | 165k | 45.23 | |
Xenon Pharmaceuticals (XENE) | 1.3 | $7.3M | 239k | 30.42 | ||
Lantheus Holdings Inc Common Stock Usd 0.01 Call Option (LNTH) | 1.2 | $6.6M | NEW | 100k | 66.02 | |
Intercept Pharmaceuticals In (ICPT) | 1.1 | $6.3M | +1194% | 455k | 13.80 | |
Tracon Pharmaceuticals Com New (TCON) | 1.0 | $5.6M | 2.8M | 2.00 | ||
Reata Pharmaceuticals Cl A (RETA) | 1.0 | $5.6M | -75% | 183k | 30.38 | |
Vaxcyte (PCVX) | 0.9 | $4.9M | -28% | 226k | 21.76 | |
Galapagos Nv Spon Adr (GLPG) | 0.9 | $4.8M | 87k | 55.60 | ||
Scpharmaceuticals (SCPH) | 0.8 | $4.3M | -8% | 884k | 4.82 | |
Harmony Biosciences Hldgs In (HRMY) | 0.8 | $4.2M | NEW | 86k | 48.77 | |
Pfizer (PFE) | 0.8 | $4.2M | 80k | 52.42 | ||
Neurocrine Biosciences (NBIX) | 0.7 | $3.8M | -91% | 39k | 97.49 | |
Miragen Therapeutics Call Option (VRDN) | 0.6 | $3.5M | NEW | 300k | 11.57 | |
Kraneshares Tr Csi Chi Internet (KWEB) | 0.6 | $3.3M | NEW | 100k | 32.77 | |
Blueprint Medicines Call Option (BPMC) | 0.6 | $3.2M | 64k | 50.50 | ||
Athira Pharma Call Option (ATHA) | 0.5 | $3.0M | 984k | 3.05 | ||
Iveric Bio Call Option (ISEE) | 0.5 | $2.8M | +497% | 294k | 9.62 | |
Satsuma Pharmaceuticals Ord (STSA) | 0.5 | $2.7M | 653k | 4.14 | ||
Insmed Com Par $.01 (INSM) | 0.4 | $2.5M | NEW | 125k | 19.72 | |
Viking Therapeutics (VKTX) | 0.4 | $2.4M | +56% | 835k | 2.89 | |
Cogent Biosciences (COGT) | 0.4 | $2.3M | NEW | 250k | 9.02 | |
Adicet Bio (ACET) | 0.4 | $2.1M | -74% | 143k | 14.60 | |
Iteos Therapeutics Call Option (ITOS) | 0.4 | $2.1M | NEW | 100k | 20.61 | |
Lyra Therapeutics (LYRA) | 0.4 | $2.0M | -17% | 347k | 5.65 | |
Seres Therapeutics (MCRB) | 0.3 | $1.9M | -35% | 541k | 3.43 | |
Arcus Biosciences Incorporated Put Option (RCUS) | 0.3 | $1.9M | -51% | 73k | 25.32 | |
Bridgebio Pharma Call Option (BBIO) | 0.3 | $1.8M | NEW | 200k | 9.09 | |
Astria Therapeutics (ATXS) | 0.3 | $1.8M | +542% | 592k | 3.00 | |
Terns Pharmaceuticals (TERN) | 0.3 | $1.7M | NEW | 700k | 2.48 | |
X4 Pharmaceuticals (XFOR) | 0.3 | $1.6M | +22% | 1.7M | 0.96 | |
Aldeyra Therapeutics (ALDX) | 0.3 | $1.5M | 375k | 3.99 | ||
Dbv Technologies S A Sponsored Adr (DBVT) | 0.3 | $1.4M | 317k | 4.42 | ||
Immatics SHS (IMTX) | 0.2 | $1.4M | -79% | 157k | 8.71 | |
Vascular Biogenics (VBLT) | 0.2 | $1.3M | 830k | 1.61 | ||
Aadi Bioscience (AADI) | 0.2 | $1.3M | +97% | 412k | 3.09 | |
Merus N V (MRUS) | 0.2 | $1.2M | 54k | 22.64 | ||
Cabaletta Bio (CABA) | 0.2 | $1000k | -35% | 944k | 1.06 | |
Chemomab Therapeutics Sponsored Ads (CMMB) | 0.2 | $992k | 268k | 3.70 | ||
Ardelyx (ARDX) | 0.2 | $991k | NEW | 1.7M | 0.59 | |
Anebulo Pharmaceuticals (ANEB) | 0.2 | $942k | 181k | 5.20 | ||
Finch Therapeutics (FNCH) | 0.2 | $938k | 331k | 2.84 | ||
Chimerix (CMRX) | 0.2 | $917k | -47% | 441k | 2.08 | |
Autolus Therapeutics Spon Ads (AUTL) | 0.2 | $912k | -13% | 322k | 2.83 | |
Tricida Put Option (TCDA) | 0.2 | $899k | 93k | 9.68 | ||
Fulcrum Therapeutics Call Option (FULC) | 0.2 | $893k | NEW | 182k | 4.90 | |
Eledon Pharmaceuticals (ELDN) | 0.2 | $884k | 363k | 2.44 | ||
Rigel Pharmaceuticals Com New (RIGL) | 0.1 | $794k | -67% | 703k | 1.13 | |
Clovis Oncology (CLVSQ) | 0.1 | $761k | -45% | 422k | 1.80 | |
Ayala Pharmaceuticals Incorporated (AYLA) | 0.1 | $759k | 697k | 1.09 | ||
Protara Therapeutics Com Stk (TARA) | 0.1 | $756k | -13% | 258k | 2.93 | |
Aileron Therapeutics | 0.1 | $752k | 2.9M | 0.26 | ||
Gemini Therapeutics | 0.1 | $749k | 443k | 1.69 | ||
Brainstorm Cell Therapeutics Com New (BCLI) | 0.1 | $698k | -16% | 253k | 2.75 | |
Pardes Biosciences (PRDS) | 0.1 | $687k | -30% | 224k | 3.07 | |
Bellicum Pharmaceuticals Com New (BLCM) | 0.1 | $617k | 523k | 1.18 | ||
Contrafect Corp Com New Put Option (CFRX) | 0.1 | $615k | NEW | 200k | 3.08 | |
Synaptogenix Com New (SNPX) | 0.1 | $614k | -20% | 121k | 5.07 | |
Renovacor | 0.1 | $595k | -14% | 293k | 2.03 | |
Connect Biopharma Hldgs Ads (CNTB) | 0.1 | $591k | 678k | 0.87 | ||
Inhibrx (INBX) | 0.1 | $561k | -79% | 49k | 11.36 | |
Synlogic (SYBX) | 0.1 | $545k | -8% | 474k | 1.15 | |
Evolus (EOLS) | 0.1 | $529k | NEW | 46k | 11.62 | |
Reneo Pharmaceuticals (RPHM) | 0.1 | $491k | 186k | 2.65 | ||
Immunic (IMUX) | 0.1 | $428k | +100% | 123k | 3.48 | |
Casi Pharmaceuticals Com New (CASI) | 0.1 | $378k | NEW | 132k | 2.86 | |
Nextcure (NXTC) | 0.1 | $336k | -49% | 71k | 4.70 | |
Wave Life Sciences SHS (WVE) | 0.1 | $318k | -90% | 98k | 3.24 | |
Zai Lab Adr (ZLAB) | 0.1 | $278k | -39% | 82k | 3.40 | |
Verastem (VSTM) | 0.0 | $265k | -66% | 228k | 1.16 | |
Praxis Precision Medicines I Call Option (PRAX) | 0.0 | $263k | NEW | 107k | 2.45 | |
Immunoprecise Antibodies Com New (IPA) | 0.0 | $237k | -20% | 61k | 3.86 | |
Hepion Pharmaceuticals (HEPA) | 0.0 | $235k | -29% | 410k | 0.57 | |
Corbus Pharmaceuticals Hldgs (CRBP) | 0.0 | $217k | -13% | 863k | 0.25 | |
Regulus Therapeutics (RGLS) | 0.0 | $217k | NEW | 105k | 2.06 | |
Verona Pharma Sponsored Ads (VRNA) | 0.0 | $200k | NEW | 300k | 0.67 | |
Mereo Biopharma Group Ads (MREO) | 0.0 | $199k | -32% | 616k | 0.32 | |
Yumanity Therapeutics | 0.0 | $190k | -55% | 104k | 1.82 | |
Aslan Pharmaceuticals Ads (ASLN) | 0.0 | $185k | 971k | 0.19 | ||
Clene Common Stock (CLNN) | 0.0 | $177k | -86% | 70k | 2.53 | |
Mymd Pharmaceuticals (MYMD) | 0.0 | $176k | -38% | 81k | 2.17 | |
Mustang Bio (MBIO) | 0.0 | $145k | -54% | 247k | 0.59 | |
Tempest Therapeutics (TPST) | 0.0 | $132k | 62k | 2.13 | ||
Stealth Biotherapeutics Corp Sponsored Ads | 0.0 | $127k | 502k | 0.25 | ||
Cyclacel Pharmaceuticals (CYCC) | 0.0 | $113k | 105k | 1.08 | ||
Larimar Therapeutics (LRMR) | 0.0 | $100k | 52k | 1.94 | ||
Inventiva Sa Ads (IVA) | 0.0 | $93k | 16k | 5.97 | ||
Bright Minds Biosciences (DRUG) | 0.0 | $86k | 106k | 0.81 | ||
Mind Medicine Mindmed Com Sub Vtg | 0.0 | $68k | 106k | 0.64 | ||
Ovid Therapeutics (OVID) | 0.0 | $59k | -96% | 27k | 2.20 | |
Enveric Biosciences Com New | 0.0 | $48k | -47% | 224k | 0.21 | |
Altamira Therapeutics SHS | 0.0 | $36k | -76% | 75k | 0.48 | |
Baudax Bio Com New | 0.0 | $3.0k | 3.0k | 1.01 | ||
Otonomy (OTIC) | 0.0 | $0 | -99% | 180.00 | 0.00 | |
Chinook Therapeutics (KDNY) | 0.0 | $0 | NEW | 332k | 0.00 |
Past Filings by Ikarian Capital
SEC 13F filings are viewable for Ikarian Capital going back to 2019
- Ikarian Capital 2022 Q2 filed Aug. 12, 2022
- Ikarian Capital 2022 Q1 filed May 13, 2022
- Ikarian Capital 2021 Q4 filed Feb. 14, 2022
- Ikarian Capital 2021 Q3 filed Nov. 15, 2021
- Ikarian Capital 2021 Q1 restated filed Aug. 18, 2021
- Ikarian Capital 2021 Q2 restated filed Aug. 18, 2021
- Ikarian Capital 2021 Q2 filed Aug. 16, 2021
- Ikarian Capital 2021 Q1 filed May 17, 2021
- Ikarian Capital 2020 Q4 filed Feb. 12, 2021
- Ikarian Capital 2020 Q3 filed Nov. 16, 2020
- Ikarian Capital 2020 Q2 filed Aug. 14, 2020
- Ikarian Capital 2020 Q1 filed May 15, 2020
- Ikarian Capital 2019 Q4 filed Jan. 31, 2020